DCM
WST icon

Dynamic Capital Management’s West Pharmaceutical WST Stock Holding History

Dynamic Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,649
Closed -$574K – 120
2018
Q3 		$574K Buy
+4,649
New +$521K 0.77% 30
2018
Q1 		– Sell
-28,979
Closed -$2.86M – 253
2017
Q4 		$2.86M Buy
28,979
+10,880
+60% +$1.07M 0.98% 23
2017
Q3 		$1.74M Sell
18,099
-8,517
-32% -$771K 0.5% 51
2017
Q2 		$2.52M Buy
+26,616
New +$2.45M 0.57% 46

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Dynamic Capital Management's WST Position: Q4 2018 in Review

Dynamic Capital Management sold out of West Pharmaceutical (WST) in Q4 2018, closing a stake of 4,649 shares — an estimated $574K sold.

Dynamic Capital Management first reported a position in WST in Q2 2017 and held it in 4 quarters. The position peaked at $2.86M in Q4 2017. 355 funds tracked by Wall St. Rank hold WST as of Q4 2018.

  • Dynamic Capital Management reported no remaining West Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • Dynamic Capital Management sold 4,649 West Pharmaceutical shares in Q4 2018, an estimated $574K.
  • Dynamic Capital Management first reported a position in West Pharmaceutical in Q2 2017 and held it in 4 quarters.
  • Dynamic Capital Management's West Pharmaceutical position peaked at $2.86M in Q4 2017.
  • 355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2018.

Based on Dynamic Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.